Following the screening, Jim Endersby, Ph.D., Professor of the History of Science at the University of Sussex, and moderator Robert J. Howell, Ph.D., Yasser El-Sayed Professor and Chair of the ...

Artificial Intelligence (AI) systems are increasingly sophisticated, and with these advancements comes a growing concern about their ability to bypass ethical restrictions intended to guide their ...

The second half of 2022 brought the first gene therapies for hemophilia to the market in both the United States and abroad. The second half of 2022 brought the first gene therapies for hemophilia to ...

Remote technology has quickly become a critical element of clinical trials. According to a June 2021 survey from WCG, 94% of research sites expect to use at least one form of remote technology in the ...

Speakers at the European Respiratory Society Congress 2024 highlighted the potential of artificial intelligence (AI) in transforming respiratory health care, while also raising important ethical ...

Many drug trials are vetted by companies with ties to the drugmakers, raising concerns about conflicts of interest and ...

The ethical considerations associated with generative AI are diverse and vast. Research about AI ethics is emerging at a precipitous pace. Thus, the goal of this resource is to provide a succinct ...

Predicting prognosis is as old as medicine itself. Recent breakthroughs in artificial intelligence (AI) and machine learning have led to algorithms that promise to answer one of life’s ultimate ...